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Summary 
Adherence to mammalian host tissues is an important virulence trait in microbial pathogenesis, 
yet little is  known  about  the  adherence mechanisms  of mycobacteria.  Here,  we  show  that 
binding ofmycobacteria to epithelial cells but not to macrophages can be specifically inhibited 
by sulfated carbohydrates. Using heparin-Sepharose chromatography, a 28-kD heparin-binding 
protein was purified from culture supematants and cell extracts ofMycobacterium  bovis and My- 
cobacterium tuberculosis. This protein, designated heparin-binding hemagglutinin  (HBHA), pro- 
motes the agglutination of rabbit erythrocytes, which is specifically inhibited by sulfated carbo- 
hydrates.  HBHA  also  induces  mycobacterial  aggregation,  suggesting  that  it  can  mediate 
bacteria-bacteria interactions as well. Hemagglutination, mycobacterial aggregation, as well as 
attachment to epithelial cells are specifically inhibited in the presence of anti-HBHA antibod- 
ies.  Immunoelectron microscopy using anti-HBHA monoclonal antibodies revealed that the 
protein is surface exposed, consistent with a role in adherence. Immunoblot analyses using an- 
tigen-specific  antibodies indicated that HBHA is different from the fibronectin-binding pro- 
teins of the antigen 85 complex and p55, and comparison of the NH2-terminal amino acid se- 
quence of purified HBHA with the protein sequence data bases did not reveal any significant 
similarity with other known proteins. Sera from tuberculosis patients but not from healthy in- 
dividuals were found to recognize  HBHA, indicating its  immunogenicity in humans  during 
mycobacterial infections. Identification of putative mycobacterial adhesins,  such as the one de- 
scribed in this report, may provide the basis for the development of new therapeutic and pro- 
phylactic strategies  against  mycobacterial diseases. 
M 
embers  of the  mycobacterial genus  are  among  the 
.most prominent pathogens causing infectious disease 
in both humans and animals.  Tuberculosis, caused by Myco- 
bacterium tuberculosis, results in r  million deaths every year 
(1, 2). Leprosy, a result of infection with Mycobacterium  lep- 
rae, remains  a  significant unsolved health  problem in  the 
developing world (3). Infections by members of the Myco- 
bacterium  avium-intracellulare  complex are  among  the  most 
frequent opportunistic infections found in patients suffering 
from acquired immunodeficiency syndrome (4, 5). In addi- 
tion, the recent dramatic resurgence of tuberculosis in de- 
veloped countries together with the emergence and spread 
of drug-resistant M.  tuberculosis strains  (6) highlights the dif- 
ficulties in controlling mycobacterial diseases. 
Despite the importance ofmycobacterial infections, little 
is  known  about  the  primary  molecular  mechanisms  in- 
volved in the pathogenesis of these diseases (7). One of the 
initial  events in bacterial pathogenesis is the adherence of 
the microorganism to its target tissues. Although mycobac- 
teria have a tropism for pulmonary macrophages (8), inter- 
actions with epithelial cells or with the extracellular matrix 
(ECM) 1 during initial adherence and subsequent coloniza- 
tion  steps  of pathogenesis  may be  critical events  (9,  10). 
There is increasing evidence that interactions with epithe- 
lial  cells  constitute important steps  in  the  pathogenesis of 
mycobacterial diseases  which  could result in  extrapulmo- 
nary dissemination of these microorganisms (11,  12). 
Many pathogens,  including respiratory pathogens,  have 
recently been shown to produce heparin-binding adhesins 
that interact with sulfated glycoconjugates that are present 
on  the  surface  of virtually  all  epithelial  cells  and  in  the 
1Abbreviations used in this paper: CHO, Chinese hamster ovary  cells; ECM, 
extracellular matrix; FHA, filamentous hemagglutinin; GAG, glycosami- 
noglycans; HBHA, heparin-binding  hemagglutinin. 
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sulfated  glycosaminoglycans  (GAG)  as  ligands  for  viruses 
(14-16),  parasites  (17-19),  mycoplasma  (20),  and bacteria 
(21-24).  The frequency and ubiquitous distribution of sul- 
fated  glycoconjugates  on  cell  surfaces  and  in  the  ECM 
make them well-suited for microbial attachment and tissue 
penetration. 
In this study, we  have identified and partially character- 
ized a novel 28-kD surface-exposed heparin-binding hemag- 
glutinin (HBHA)  produced by M.  bovis  and M.  tuberculosis 
and  provide  evidence  that  it  mediates  bacteria-epithelial 
cell interactions. This protein is also  able to induce myco- 
bacterial auto-aggregation which suggests that it could pro- 
mote  mycobacterial  colonization at  the  site  of attachment 
of the pathogen to host tissues. 
Materials and Methods 
Mycobacterial Adherence Assays.  Exponentially growing M.  bo- 
vis BCG  (strain  1173P2;  World Health Organization, Stockholm, 
Sweden, passage 3 to 8) were labeled by culturing the mycobacte- 
ria for 3 d  in Sauton medium containing 5 IxCi/ml [6-3H]uracil 
(24 Ci/mmol; DuPont/New England Nuclear, Boston, MA). The 
mycobacteria were  then harvested by centrifugation (3000 g for 
5 rain), washed twice with Dulbecco's phosphate-buffered saline 
(DPBS), and resuspended in RRPMI 1640 culture medium containing 
300 mg/l g-glutamine (GIBCO BILL, Gaithersburg, MD) with- 
out added fetal serum (RRPMI). The day before the adherence as- 
say,  the  wells  of 24-well  tissue  culture  trays  (Nunclon, Nunc, 
Denmark) were seeded with 10  s freshly grown Chinese hamster 
ovary (CHO)  cells orJ774A.1  macrophage cells  (TIB67; Ameri- 
can  Type  Culture  Collection,  1<ockville, MD)  resuspended  in 
2 nfl 1<PMI supplemented with 10%  (vol/vol) decomplemented 
fetal calf serum (1<PMI-FCS). The cells were washed three times 
with 2 ml RPMI, and 1 ml ofmycobacterial suspension in 1<PMI 
was added to each well to obtain a multiplicity of infection of an 
estimated  10  bacteria  per  cell.  The  adherence  assay  was  per- 
formed in the presence of increasing concentrations of D(+)ga- 
lactose  (Sigma Chem.  Co.,  St.  Louis, MO)  or porcine intestine 
nmcosal heparin (M~ 6 kD; Sigma), or with 20 I.~g/ml of the indi- 
cated carbohydrates  (Sigma).  After 6  h  of incubation at 37~  in 
5% CO2, the cells were washed three times with 2 ml DPBS, and 
lysed by adding 1 ml distilled water containing 0.1%  (wt/vol) so- 
dium deoxycholate. The radioactivity associated with the cellular 
lysates was determined using a liquid scintillation counter (model 
LS 6000SC; Beckman Instruments, Carlsbad, CA). RResidual ad- 
herence is expressed as the percent of radioactivity relative to that 
obtained in the absence of carbohydrate or antibodies, assayed in 
quadruplicate. For monoclonal antibody (mAb) inhibition exper- 
iments, radiolabeled M.  tuberculosis H37RRa or BCG were first in- 
cubated with a serial dilution of purified mAb 4057D2 (25) or an 
irrelevant  mAb  and  then  assayed  for  attachment  as  described 
above after a 90-rain incubation period. 
Pur~cation  of a  Heparin-binding  Protein from  M.  bovis BCG. 
M. bovis BCG was grown in static cultures at 37~  using 175 cm  2 
Roux flasks (Falcon; Becton-Dickinson, Franklin Lakes,  NJ) con- 
taining ~-~150 ml  of Sauton  medium.  At  stationary phase,  the 
cultures were  centrifuged (10,000 g for 20 rain), and 500 ml of 
supernatant was passed through a heparin-Sepharose CL-6B (Phar- 
macia  LKB,  Piscataway,  NJ)  column  (1  ￿  5  cm)  equilibrated 
with DPBS.  The column was then washed with  100 ml DPBS, 
and the bound material was eluted by a 0-500 mM NaC1 gradient 
in 100 ml DPBS. The flow rate during all steps was maintained at 
1.5  ml  per  min,  and  absorbance  at  280  nm was  continuously 
monitored.  The  eluted  1-ml fractions  were  analyzed by  SDS- 
PAGE using a 12% gel (26) followed by Coomassie Brilliant Blue 
1<-250 staining. 
Mycobacterial Cell Wall Extract Preparations.  Mycobacteria  were 
grown in 2 1 of Sauton or Long's synthetic medium (Quality Bio- 
logical Inc., Gaithersburg, MD) until late-log phase. The bacteria 
were then pelleted by centrifugation, washed once in DPBS con- 
taining 0.05% Tween 80 (DPBS/Tw), resuspended in 100 ml of 
DPBS/Tw, and heated at 80~  for 1 h. The bacteria were centri- 
fuged  at  13,000 g  for  20  min, washed  with  DPBS/Tw,  resus- 
pended in 25  ml of DPBS/Tw  containing 5  mM of protease 
inhibitor 4-(2-aminomethyl)-benzenesulfonyl  fluoride hydrochlo- 
ride, RNaseA and DNaseI. The mixture was sonicated intermit- 
tently for 25 min on ice, and then centrifuged at  13,000 g for 20 
min. The  sonication and centrifugation steps  were  repeated  on 
the cell pellet, and the supernatants were pooled and centrifuged 
at 34,000 g for 3 h. The pellet was discarded, and the final super- 
natant was diluted 1:2 in DPBS, chromatographed over heparin- 
Sepharose CL-6B, and eluted as described above. 
HemagglutinationActivity.  The  hemagglutination  activity  of 
HBHA purified from culture supematants was assayed in U-shaped 
microtiter plates (Falcon; Becton-Dickinson, Franklin Lakes,  NJ) 
in the absence or presence of porcine intestine mucosal heparin, 
dextran sulfate or dextran at concentrations ranging from 0 to 50 
I~g/ml.  Standard  assays contained  70  I*1  of a  5%  fresh  rabbit 
erythrocyte suspension prepared in DPBS  and 7(i) txl of purified 
HBHA corresponding to  1 ~g of protein. Hemagglutination ti- 
ters were  read after 5 h  of incubation at room temperature.  For 
mAb inhibition studies, serial dilutions of purified mAb 40571)2 
or an irrelevant mAb were  pre-incubated with HBHA and he- 
magglutination was determined as described above. 
Auto-aggregation Activity.  Bacteria  were  washed  three  times 
using DPBS and centrifuged for 5 rain at 200 g to remove large 
aggregates  of bacteria. Resuspended bacteria were  sonicated for 
10  s and passed through  a  22-gauge  needle five times.  Purified 
HBHA was serially diluted in 100 b~l of DPBS in U-bottom nli- 
crotiter plates (Nunclon, Nunc, Denmark), and 100 ~1 of an esti- 
mated  10  s bacteria per ml were  added to  the wells. Plates were 
agitated and examined macroscopically for aggregation after a 3{)- 
min incubation at room temperature. 
Electron Microscopy.  Mycobacteria were harvested and washed 
in DPBS as described above and fixed in 2% paraformaldehyde at 
room temperature overnight. Bacteria were  incubated in DPBS 
containing 0.1  M  glycine to remove residual fixative, washed in 
DPBS containing 0.5% BSA (DPBS/BSA),  and cell pellets were 
incubated with 50 b~l of 3921E4 or 4057D2 ascites  (25) in 1 ml of 
DPBS/BSA for 2 h at room temperature. After two washes with 
DPBS/BSA, the bacteria were incubated for 1 h at room temper- 
ature with goat anti-mouse IgG-G10 (Amersham Life Sciences, 
Arlington Heights,  IL)  diluted  1:3  in  DPBS/BSA.  Cells  were 
fixed  overnight  in  2%  glutaraldehyde/2%  parafornlaldehyde  in 
0.1  M  sodium cacodylate buffer, pH 7.3.  The fixative was then 
removed and the samples stored in I)PBS containing 4% sucrose 
at 4~  until they were subsequently dehydrated with graded alco- 
hols  and embedded  in epoxy resin. Thin sections were  stained 
with uranyl acetate and lead citrate and examined with a EM 912 
electron microscope (Carl Zeiss Inc., Thornwood, NY). 
Antibody Production.  Rat anti-HBHA polyclonal antibodies were 
prepared  as follows:  200  b~g of purified BCG  HBHA was  sub- 
jected to preparative electrophoresis on a 15% polyacrylamide gel 
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cellulose metaabrane. After rapid staining with Ponceau Red, the 
band corresponding to  HBHA  was  carefully  excised,  cut  into 
small squares, and briefly sonicated in 1.5 ml sterile DPBS.  After 
the addition of I nil ofa monophosphoryl lipid A solution (MPL + 
TDM Adjuvant System;  Sigma) prepared  according to  the rec- 
ommendation of the manufacturer, two  Fischer  rats were  each 
immunized  with 1 ml of the antigen suspension.  For each animal, 
400 I*1 were given intraperitoneally, followed by two subcutane- 
ous injections of 300 t*l. The animals were boosted the same way 
with the same amount of antigen one month later, and the serum 
was collected 3 wk aSer the boost. The establishment ofhybridomas 
producing the mAbs 4057D2 and 3921E4 has been described else- 
where (25). mAb 4057D2, IgG  3 isotype, was purified by cryopre- 
cipitation using dialysis in 0.01M  Tris  (pH  8)  buffer  and mAb 
3921E4, IgG2~ isotype, was purified by protein A-Sepharose  chro- 
matography. Purified mAbs BPG10 and X3E were obtained from 
the anti-Bordetelta pertussis  antibody collection of CBER, FDA. 
Analytical  Procedures.  Immunoblot  analyses were performed us- 
ing standard  procedures as described  by Harlow and Lane  (27). 
To identify the presence of anti-HBHA antibodies in human sera, 
nitrocellulose membranes containing 5 ~g of purified HBHA per 
lane were probed with a 100-fold dilution of human sera and de- 
tected as described  above (27). Protein concentrations were de- 
termined by the method of Bradford  (28) using BSA as a stan- 
dard.  NHi-terminal amino acid sequencing was done as follows: 
25 txg of HBHA was subjected to SDS-PAGE using a 15% poly- 
acrylamide  gel  and after  electrophoresis  the  material  was  trans- 
ferred onto a PVDF membrane (ProBlott;  AB1, Foster City, CA) 
by electroblotting. After staining with Coomassie  Blue, the band 
corresponding to HBHA was excised and submitted to automated 
Edman degradation.  A database search in Swiss-PROT for 100% 
identity was performed. 
Results 
Inhibition  of Mycobacterial  Adherence  to  Epithelial  Cells  by 
Sulfated  Carbohydrates.  To determine if mycobacteria can 
adhere to eukaryotic cells via sulfated glycoconjugates, we 
tested whether soluble carbohydrates reduce adherence of 
M.  bovis  BCG to epithelial cells. As shown in Fig.  1 A, as 
little  as  10  btg  per  ml  of heparin  significantly inhibited 
[3H]uracil-labeled BCG adherence to CHO  cells, whereas 
no effect was observed with the addition of up to 100 gtg per 
nil of the non-sulfated sugar D(+)galactose. While heparin- 
mediated inhibition of adherence was saturable, the inhibi- 
tion of adherence did not exceed 70%, indicating that other 
mechanisms of attachment are also involved. Dextran sul- 
fate, fucoidan and chondroitin sulfate, at a sugar concentra- 
tion of 20/.~g per ml, were also able to reduce adherence, 
but no significant inhibition was observed using the non- 
sulfated sugars  dextran,  mannose, or  galactose  (Fig.  1  B). 
Interestingly, interactions of BCG  with J774A.I  macro- 
phage-like ceils  were  not affected by the sulfated carbohy- 
drates,  nor by non-sulfated sugars (Fig.  1 B),  even at con- 
centrations up  to  1  mg per ml  (data  not shown).  This is 
consistent with  previous  reports  implicating complement 
receptors  CP,1,  CR3,  and  CR4  as  mycobacterial ligands 
on  the  surface  of blood  monocytes  and  alveolar  macro- 
phages (29-3l), 
Figure 1.  Effect of sulfated and non-sulfated carbohydrates on myco- 
bacterial adherence  to CHO cells and macrophages. Exponentially  grow- 
ing M.  bovis BCG were metabolically  labeled and incubated with freshly 
grown CHO cells (A and B, gray bars) or J774A. 1 macrophages (B, black 
bars). The adherence assay was performed in the presence of increasing 
concentrations of D(+)galactose (A,  black circles), porcine intestine mu- 
cosal heparin (A, white circles), or with 20 Ixg/ml of the indicated  carbohy- 
drates (B). After 6 h of incubation, the radioactivity  associated with the 
cellular lysates was determined, and residual adherence was expressed as 
percent of cpm relative to the cpm obtained in the absence of carbohy- 
drate (control). The  data represent averages for quadruplicate experi- 
ments, and standard deviation  bars are shown. 
Purification of a Heparin-binding  Protein.  The  inhibition of 
BCG  adherence  to  epithelial cells by sulfated sugars  sug- 
gests that mycobacteria express an adhesin which interacts 
with  sulfated glycoconjugates on  eukaryotic  cell  surfaces. 
As has been shown for other bacteria (32), surface-exposed 
adhesins may be partially released into the culture medium. 
Therefore, in order to identify putative adhesins, BCG cul- 
ture  supernatants were  fractionated by heparin-Sepharose 
chromatography.  The  bound material  was  eluted  with  a 
NaC1 gradient, and the  eluted fractions were  analyzed by 
SDS-PAGE.  As  shown  in  Fig.  2,  a  28-kD  protein  was 
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BCG, M. boris BCG was grown to stationary phase, and 500 ml of super- 
natant  were  loaded  onto  a  heparin-Sepharose  CL-6B  column.  After 
washing, the column was eluted with a 0-500 rnM NaC1 gradient, and 
eluted fractions were  analyzed by S1)S-PAGE followed by Coomassie- 
Blue staining. Fractions eluted in the protein peak at ~350 mM NaC1 are 
shown  in lanes  1-8.  The right lane shows the heparin-binding protein 
purified from a M.  bovis BCG cell extract preparation.  Migration of the 
molecular mass markers is illustrated in the right margin. 
Figure 3.  Comparison of the M. bovis heparin-binding  protein with the 
85 antigen complex. The heparin-binding  protein purified from M. boris 
BCG cell extracts (lanes 1) or culture supernatant (lanes 2) was compared 
with the purified antigen 85 complex  (lanes 3) by imnmnoblot analysis 
(A-C) and Coomassie Blue staining (I)) after SDS-PAGE.  lmmunoblot 
analyses  were performed using polyclonal antibodies raised against the pu- 
rified heparin-binding  protein (A), the anti-HBHA mAb 40571)2 (B), or 
polyclonal antibodies raised against the antigen 85 complex (C). Lanes 1 
and 2 of A-C contain 2 Ixg of purified protein, lanes 3 of A-C contain 
7 Ixg of purified protein, lanes 2 and 3 olD contain 4 and 15 Ixg of puri- 
fied protein,  respectively. The position of the molecular mass markers is 
shown in the margin. 
eluted  at  ~350  mM  NaC1.  The  interaction between this 
protein and heparin appears  to  be  dependent on the sugar 
sulfation,  because  it  could  also  be  purified  using  dextran 
sulfate beads, but not with dextran beads (data not shown). 
To determine whether this protein is strictly secreted  or 
also surface associated, cell wall extracts from BCG were pre- 
pared  and then chromatographed  over heparin-Sepharose. 
As  shown  in  Fig.  2,  the  28-kD  heparin-binding protein 
was  also  present  in  these  preparations,  suggesting  that  it 
may  be  surface-associated.  A  similar size  heparin-binding 
protein was also purified from M.  bovis Ravenel and M.  tu- 
berculosis H37Ra cell wall extracts and from tuberculin (pu- 
rified protein  derivative skin test  antigen) preparations  de- 
rived from culture filtrates of M.  tuberculosis (data not shown). 
Cell Smface Localization of the Mycobaaerial Heparin-binding 
Protein.  The presence of the 28-kD heparin-binding pro- 
tein  in  culture  supernatants  and  cell  wall  extracts  suggest 
that  it  may be  located  at  the  cell surface  and partially re- 
leased into the  culture supernatant.  Since the protein does 
not appear to  be species specific,  a bank of mAbs directed 
against M.  avium antigens (25) was screened to identify an- 
tibodies reactive with the heparin-binding protein. Two  of 
the  mAbs  (4057D2  and  3921E4)  recognized  the  28-kD 
protein  isolated from BCG  (Fig.  3  B),  from M.  tuberculosis 
and from M.  bovis  (data not shown). 
These  antibodies were  then  used  for  the  imrnunoelec- 
tron  microscopy  studies  to  investigate  the  localization  of 
this protein on the bacteria. As shown by the gold-labeling 
in Fig. 4, A  and B,  the heparin-binding protein was found 
to be surface-exposed  on M.  tuberculosis  H37P, a,  consistent 
with  the  fractionation  experiments  and  with  a  potential 
role of this surface protein in adherence. 
Identification qf the Heparin-binding Protein as a Novel Myco- 
bacterial Antigen.  Since  the  size  of  the  28-kD  heparin- 
Figure  4.  hnmunoelectron micrographs  of M.  tuberculosis. A  and B 
show M.  tuberculosis H37Ra after incubation with n~Abs  that specifically 
recognize HBHA followed by gold-labeled (10 nm) goat anti-mouse im- 
munoglobulin. A (￿  using  n~b 3921E4 and B (￿  using 
mAb 4057D2 illustrate that the surface of the bacterium is unifomfly la- 
beled. 
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Adherence, and Mycobacterial Aggregation by Anti-HBHA 
Monodonal Antibodies 





I  Agglutination of RBC  4057D2  10 
BPG10  >150 
II  Adherence ofM. tb H37Ra  4057D2  5 
to CHO cells  BPG10  >50 
III  Aggregation ofM. tb H37Ra  4057D2  2.5 
X3E  > 100 
*  Bioassays were performed as described in Materials and Methods using 
l ~g/rnl of HBHA for the hemagglutination and aggregation assays and 
radiolabeled-H37Ra bacteria for the adherence assay. 
*  4057D2 is purified IgG mAb directed against HBHA of mycobacteria; 
BPG10 is purified IgG mAb directed against lipooligosaccharide of  B. Per- 
tussis; X3E is purified IgG mAb directed against the B. penussis adhesin 
filamentous hemagglutinin. 
Maximum inhibition is the concentration of  mAb that gives a complete 
inhibition ofhernagglutination and aggregation, or inhibits attachment 
ofmycobacteria to CHO cells by 50%. 
binding protein is similar to that of the fibronectin-binding 
antigen 85 complex proteins (33), immunoblot analysis was 
used  to determine  whether  they are  related.  Fig.  3  shows 
that polyclonal and mAbs directed against the 28-kD pro- 
tein  did  not  recognize  the  purified  antigen  85  complex 
proteins.  Conversely, polyclonal as well as mAbs (data not 
shown)  raised against the BCG  antigen  85  complex failed 
to recognize the 28-kD protein, implying that they are dis- 
tinct proteins.  This finding is also supported by the  differ- 
ent migration patterns of these proteins during SDS-PAGE 
(Fig.  3  D).  Similar  experiments  using  antibodies  directed 
against the p55 Mycobacterium  vaccae FAP protein  (34)  indi- 
cate no antigenic cross-reactivity between this fibronectin- 
binding  protein  and  the  28-kD  heparin-binding  protein 
(data not shown). 
To further characterize the 28-kD protein, it was subjected 
to NH2-terminal  amino acid sequencing after purification 
from BCG.  The first  16  amino  acids  were Ala-Glu-Asn- 
Ser-Asn-Ile-Asp-Asp-Ile-Lys-Ala-Pro-Leu-Leu-Ala-Ala. The 
NH2-terminal  amino  acids  of the  heparin-binding  protein 
purified from M.  tuberculosis H37Ra cell wall extracts were 
also determined and found to be identical to that of the pro- 
tein purified from BCG. A  similarity search in the protein 
data  bases  revealed  that  this  amino  acid  sequence  has  not 
been previously identified,  which indicates that the 28-kD 
protein is a novel mycobacterial protein. 
Hemagglutination  and  Bacterial  Attachment  Activity  of the 
Mycobacterial Heparin-binding Protein.  The ability  of bacte- 
rial  adhesins  to  agglutinate  erythrocytes is  often  used  as  a 
model to study lectin-like microbial attachment to eukary- 
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Figure 5.  Effect  of sulfated and non-sulfated carbohydrates on HBHA- 
mediated hemagglutination. The hernagglutination activity of the BCG 
HBHA purified from culture supernatants was assayed in the presence of 
porcine intestine rnucosal heparin (black squares), dextran sulfate (black cir- 
des) or dextran (white circles) at concentrations ranging from 0 to 50 ~xg/rnl. 
Hernagglutination titers were read after 5 h of incubation at room tern- 
perature. The data represent averages for quadruplicate experintents, and 
standard deviation bars are shown. 
otic  cell  receptors  (32).  We  therefore  tested  the  purified 
heparin-binding protein for its  ability to agglutinate  eryth- 
rocytes. Less than 0.1  p~g of purified protein was able to in- 
duce  the  hemagglutination  of rabbit  erythrocytes, but not 
sheep,  goose,  chicken,  or  human  erythrocytes  (data  not 
shown).  This  hemagglutination  was  completely  inhibited 
in the presence of 10  Dg per ml of purified mAb 4057D2 
(Table  1).  For these reasons we will refer to this protein as 
HBHA. HBHA-induced hemagglutination was also inhib- 
ited  by  heparin  or  dextran  sulfate,  but  not  by  dextran 
(Fig. 5), similar to the results obtained in the CHO  cell ad- 
herence assay. 
To establish whether mycobacterial adherence to epithe- 
lial  cells  was HBHA mediated,  CHO  cells  were incubated 
with radiolabeled BCG in the presence of increasing amounts 
of anti-HBHA polyclonal antibodies or non-relevant poly- 
clonal antibodies. Adherence of BCG to CHO cells was in- 
hibited by "-~45% in the presence  of anti-HBHA antibod- 
ies.  Similar  experiments  using  M.  tuberculosis H37ka  also 
indicated that anti-HBHA mAb inhibit adherence (Table  1). 
Attachment was inhibited by 50% in the presence of 5  ~g 
per ml of purified mAb 4057D2 but not by >50 ~g per ml 
of the irrelevant  IgG mAb BPG10.  These observations in- 
dicate  that  adherence  of mycobacteria to  epithelial  cells  is 
mediated at least in part by HBHA. 
Mycobacterial Auto-aggregation Induced by HBHA.  Some ad- 
hesins  also  induce  auto-aggregation  of bacteria  (35,  36), 
and  many  mycobacterial  species  grown  in  vitro  readily 
form aggregates. Fig. 6 demonstrates that M.  tuberculosis can 
be aggregated in a dose-dependent manner by the addition 
of HBHA,  with  maximum  aggregation  starting  at  a  con- 
centration of 0.5 p~g HBHA per nO.  In contrast, 20 p~g/ml 
of purified  lipoarabinomannan  did not induce aggregation 
of the  bacteria  in this  assay.  Bacterial  clumping was  com- 
pletely inhibited by 2.5 ~g/ml of the 4057D2 mAb (Table 1), 
997  Menozzi et al. Figure  6.  HBHA-mediated aggregation of M. tuberculosis. Aggregation 
of M. tuberculosis  H37Ra was induced by incubating 10  ~ bacteria/ml with 
5,  1.25, 0.15, or 0 ~g protein/ml  final concentration (left to  r(~,ht) of 
HBHA purified from  M. tuberculosis  H37Ra. 
suggesting that HBHA is directly involved in auto-aggluti- 
nation. 
Immune  Reactivity against HBHA  in Antisera fiom  Tubercu- 
losis  Patients.  To determine if HBHA is able to induce an 
immune  response  in  humans,  immunoblot  analyses  were 
carried out using purified HBHA and human antisera from 
tuberculosis patients.  Nitrocellulose membranes containing 
HBHA were probed with  100-fold diluted sera from seven 
different  patients  diagnosed  with  active  tuberculosis  that 
had not been vaccinated with BCG. As shown in Fig. 7, all 
the sera from the tuberculosis patients  contained antibodies 
that recognize the 28-kD HBHA, whereas the serum from 
a  healthy  individual  did  not  contain  antibodies  against 
HBHA.  Four  additional  sera  from  healthy  individuals 
showed no reaction in this immunoblot assay.  These results 
indicate  that  the  surface  exposed  HBHA is  immunogenic 
during the course of tuberculosis disease. 
Figure  7.  lnnnunoblot  analysis using antisera from tuberculosis pa- 
tients. Sera from seven patients diagmosed with active tuberculosis (lanes 
labeled 468 through 493) as well as serum from a healthy subject (control 
lane) were incubated with nitrocellulose strips containing 5 l,  tg of HBHA 
and reactivity was visualized as described in Materials and Methods. The 
arrow denotes the position of  purified HBHA. 
Discussion 
In this study we describe a novel surface-associated hep- 
arin-binding  adhesin  in  mycobacteria.  As  is  the  case  for 
many bacterial adhesins,  this protein  expresses hemaggluti- 
nation  activity  and  is  therefore  referred  to  as  HBHA. 
HBHA  was  purified  by  heparin-Sepharose  chromatogra- 
phy from both culture supernatants and cell wall extracts of 
BCG and M.  tuberculosis.  This finding and the expression of 
HBHA on the  mycobacterial cell surface,  as demonstrated 
by immunoelectron microscopy, suggests that the protein is 
appropriately  positioned  for cell-cell  interactions.  Similar- 
ity  searches  of the  NH2-terminal  amino  acid  sequence  of 
purified HBHA shows no homology with known proteins 
in the protein sequence data bases. 
A  direct  role  for  HBHA  in  bacterial  adherence  is 
strongly  suggested  by  the  specific  inhibition  of HBHA- 
mediated  hemagglutination  and attachment  of mycobacte- 
ria to epithelial cells by mAb directed against HBHA. Since 
adherence of mycobacteria to epithelial cells  is also specifi- 
cally inhibited by heparin and other sulfated carbohydrates, 
it is likely that HBHA functions to mediate bacterial adher- 
ence  via  sulfated  surface  receptors  on  eukaryotic  cells.  In 
addition,  similar  to  the  Bordetella  pertussis  filamentous  he- 
magglutinin  (FHA)  (37)  and  to  the  Yersinia  enterocolitica 
YadA  (36)  proteins,  the  mycobacterial  HBHA  appears  to 
be  a nmltifunctional  adhesin,  since it is  capable  of mediat- 
ins bacterial auto-aggregation as well as bacteria-eukaryotic 
cell interactions.  The  enhancement  of inter-mycobacterial 
contact may also promote virulence through the formation 
ofmicrocolonies at the initial site of infection, analogous to 
the role played by the autoagglutination activity of group A 
streptococci M  proteins in virulence  (38). 
The exploitation  of sulfated glycoconjugates as receptors 
may be particularly advantageous for many infectious agents. 
Proteoglycans  that  consist  of a  protein  core  with  one  or 
more  covalently  attached  GAG  chains  (13)  are  expressed 
on  the  surface  of virtually  all  animal  cells  and  are  also 
present  in  the  ECM,  including  the  lung  mucosa  (39). 
There  is  evidence  that  a  number  of pathogenic  microor- 
ganisms  take  advantage  of the  widespread  distribution  of 
sulfated  glycoconjugates  on  cell  surfaces  to  use  them  as 
ligands for the attachment phase of infection. The initiation 
of human  cytomegalovirus infection  is  mediated  through 
an  interaction  with  cell  surface  heparan  sulfate  (15).  Also, 
the  circumsporozoite  protein  of Plasmodium  binds  specifi- 
cally to sulfated macromolecules such as heparin,  fucoidan, 
heparan sulfate, and dextran sulfate (18). In addition, the B. 
pertussis FHA is a nmltifunctional bacterial adhesin that binds 
to several ligands including sulfated glycoconjugates (37). 
Several  observations  strongly  imply  that  interactions  of 
pathogenic  mycobacteria  with  sulfated  carbohydrates  on 
the surface of cells  other than macrophages may contribute 
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documented  role  in  mycobacterial  infection  throughout 
the  lungs,  dissemination  of the  tubercule  bacilli  to  other 
sites via the lymphatic or circulatory system most likely re- 
quires attachment  to epithelial or endothelial  cells. Recent 
findings suggest that M.  tuberculosis may indeed  gain access 
to  the  lymphatic  and  circulatory  systems by direct  adher- 
ence and penetration  of alveolar epithelial cells (11).  Infec- 
tion of pigs with Mycobacterium  avium also involves essential 
interactions with epithelial cells for which specific receptors 
have been  postulated  but  have  not yet been  characterized 
(41).  Since  M.  avium produces  a HBHA-related protein,  it 
is tempting to speculate  that its HBHA-like protein is also 
involved in the  recognition  of epithelial  cells by M.  avium 
via interactions with sulfated GAG. In addition,  endothelial 
cells  have been  demonstrated  to  contain  large  amounts  of 
heparan sulfate and other sulfated glycoconjugates  on their 
surface  (40).  Therefore,  the  heparin-binding  activity  of 
HBHA  may be involved in  extrapulmonary  dissemination 
of M.  tuberculosis. This is reminiscent of essential steps in the 
pathogenesis  of infectious diseases caused by other invasive 
microorganisms such as  Y. enterocolitica (42). 
Furthermore,  binding  to  sulfated  sugars  may contribute 
to the spread of M.  tuberculosis via its attachment to mucus. 
Interaction of the bacteria with the sulfated polysaccharides 
contained  in  mucus  may not  only increase  the  likelihood 
for productive  interactions  with alveolar macrophages dur- 
ing the initial steps of pathogenesis but may also contribute 
significantly to the transmission of M.  tuberculosis when ex- 
haled in the form of droplet nuclei. 
In  addition  to  binding  to  GAG  receptors,  which  may 
constitute  an  initial  multivalent  low-affinity  step  in  infec- 
tion with mycobacteria, the pathogen may subsequently as- 
sociate with  greater affinity to other eukaryotic cell recep- 
tors via other regions on HBHA or through other bacterial 
ligands.  Additional  adhesins  for mycobacteria  may include 
proteins  of the  85  antigen  complex  (33)  and  p55  (34), 
which  both bind  to fibronectin.  Such  a  complex  dual  re- 
ceptor  system involving  initial  low  affinity  GAG  binding 
followed by high-affinity binding  is required  for fibroblast 
growth factor activity (43). Also, it has been suggested that 
interaction  of herpes  simplex virus  (44)  with  heparan  sul- 
fate is required to initially concentrate  the virus on the cell 
surface  and  hence  facilitate  its binding  to  other  receptors. 
Indeed, for macrophages, there is evidence for the interac- 
tion of complement receptors and mannose receptors with 
mycobacteria  (29-31).  An  additional  role  for  sulfated  re- 
ceptors  is exemplified by the  adherence  mechanisms  used 
by  Leishmania  which  interact  with  heparan  sulfate  pro- 
teoglycans on epithelial cells (19)  and with CR3  and man- 
nose receptors on mononuclear phagocytes (45, 46). 
There is an urgent need to prevent pathogenic mycobac- 
terial transmission  in endemic  areas and in health  care set- 
tings.  The  identification  of adhesins  involved in the  initial 
steps  of attachment  and  colonization  may  provide  new, 
rational approaches to block infection,  either by the devel- 
opment  of novel drugs  that  interrupt  early host-pathogen 
interactions  or  by  new  vaccine  strategies.  Since  sulfated 
polysaccharides are known to have anti-viral activity against a 
number  of enveloped  viruses,  heparin  derivatives,  which 
can be administered  to humans  without  toxic  effects (47), 
are of particular interest for the development of new thera- 
peutics.  In  addition,  since  adhesins  have  proven  useful  in 
the  control  of other  infectious  diseases,  and  since  there  is 
interest in secreted mycobacterial proteins as vaccine candi- 
dates, the mycobacterial heparin-binding  protein described 
in  this  study  deserves some attention  as a  possible vaccine 
component.  The fact that the antisera from all tuberculosis 
patients studied in this report recognize HBHA further em- 
phasizes its possible immunological importance and vaccine 
potential. 
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